logo
logo

Holobiome Wins Usd1 Million In Research Funding From Csb To Advance Microbiome Solutions For Pain

Oct 28, 2021•almost 4 years ago

Amount Raised

$1 Million

Round Type

seed

Cambridge

Description

Japan's Corundum Systems Biology Inc. will contribute USD1 million to support a new 2-year research project that US life sciences startup Holobiome Inc. will launch. Holobiome's proposed project will assess the gut microbiome's role in regulating pain sensitivity, paving the way for potential microbial therapies, consumer goods, and/or diagnostics that aim to address pain in a broad range of people, such as those suffering from inflammatory bowel disease and neuropathy.

Company Information

Company

Holobiome

Location

Cambridge, Maryland, United States

About

The company offers support in microbiome advancements globally through support in development of new business, development of biometric database and data analysis platforms, and grant-giving to facilitate and accelerate R&D. (https://www.csb.co.jp/) Source: 1. Strandwitz, P. et al. GABA-modulating bacteria of the human gut microbiota. This project will enable Holobiome to engage in a comprehensive assessment of the gut-pain axis, which has the potential to generate novel microbial therapies for pain and other disease associated with inflammation, such as Alzheimer's disease and depression.